The FDA has delivered some end-of-year cheer to Vanda Pharma after approving Nereus, its drug for the prevention of motion sickness. A new white paper from Lumanity – ‘A New Framework to Engineer ...

The CLL17 trial showed noninferiority of fixed-duration regimens compared to continuous BTK inhibitor therapy, highlighting ...

The Department of Health (DOH) said on Saturday it is studying reforms to protect patients from exorbitant professional fees ...

“For many years, the standard of care for ASHL was based on the RATHL trial, where newly diagnosed patients were given two cycles of ABVD [doxorubicin, bleomycin, vinblastine, and dacarbazine] and ...

President and CEO Matthew Rowlinson sits down with Kitco Mining at the 2025 NBF CEO Mining Conference in London to walk through the company’s latest milestones at the Warintza Project in Ecuador. In ...

Toronto, Ontario--(Newsfile Corp. - December 18, 2025) - CEO.CA ("CEO.CA"), the leading investor social network in junior resource and venture stocks, shares exclusive updates with CEOs of junior ...

Toronto, Ontario–(Newsfile Corp. – December 18, 2025) – CEO.CA (“CEO.CA”), the leading investor social network in junior resource and venture stocks, shares exclusive updates with CEOs of junior ...

The latest data released at ASH 2025 offer new combination therapies for the treatment of multiple myeloma and new insights into the disease.

In the run-up to Pre-Filled Syringes West Coast in June, SMi Group caught up with Douglas Cusato from Sumitomo Rubber to discuss his presentation, current challenges and the upcoming event. A: “The ...

Find Latest Business News on Indian Economy,Top News on Monetary & Trade Policies, BSE & NSC Notices, Management Interviews & more .

ORLANDO, Fla. — Patients who took pirtobrutinib (Jaypirca) had a similar overall response rate to those who took ibrutinib. This was the case for those with both treatment-naive and ...